|   ICT5040 structure | Common Name | ICT5040 | ||
|---|---|---|---|---|
| CAS Number | 215655-21-3 | Molecular Weight | 275.250 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | 343.5±52.0 °C at 760 mmHg | |
| Molecular Formula | C10H8F3N3OS | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 161.5±30.7 °C | |
| Use of ICT5040ICT5040 is a small molecule CXCR4 antagonist (IC50=3.8 μM). ICT5040 inhibits CXCL12-mediated proliferation and migration, and suppresses CXCL12-induced intracellular calcium mobilisation in U87 glioma cells[1]. | 
| Name | 2-(methylthio)-5-[2-methyl-6-(trifluoromethyl)-3-pyridyl]-1,3,4-oxadiazole | 
|---|---|
| Synonym | More Synonyms | 
| Description | ICT5040 is a small molecule CXCR4 antagonist (IC50=3.8 μM). ICT5040 inhibits CXCL12-mediated proliferation and migration, and suppresses CXCL12-induced intracellular calcium mobilisation in U87 glioma cells[1]. | 
|---|---|
| Related Catalog | |
| Target | CXCR4:3.8 μM (IC50) | 
| In Vitro | ICT5040 (1-100 μM; 0-4 d) 剂量依赖性地抑制 CXCL12 诱导的 U87 胶质瘤细胞的增殖和迁移[1]。 ICT5040 在 U87 胶质瘤细胞中降低 CXCL12 诱导的细胞内钙动员[1]。 Cell Migration Assay [1] Cell Line: U87-glioma cells Concentration: 1 μM, 10 μM, 100 μM; with 100 ng/mL CXCL12 Incubation Time: 0, 1, 2, 3, and 4 days Result: Resulted reduction of CXCL12 induced proliferation and migration of U87 cells at day 3. | 
| References | 
| Density | 1.5±0.1 g/cm3 | 
|---|---|
| Boiling Point | 343.5±52.0 °C at 760 mmHg | 
| Molecular Formula | C10H8F3N3OS | 
| Molecular Weight | 275.250 | 
| Flash Point | 161.5±30.7 °C | 
| Exact Mass | 275.034027 | 
| LogP | 3.75 | 
| Vapour Pressure | 0.0±0.7 mmHg at 25°C | 
| Index of Refraction | 1.543 | 
| Pyridine, 2-methyl-3-[5-(methylthio)-1,3,4-oxadiazol-2-yl]-6-(trifluoromethyl)- | 
| 2-(methylthio)-5-[2-methyl-6-(trifluoromethyl)-3-pyridyl]-1,3,4-oxadiazole | 
| 2-Methyl-3-[5-(methylsulfanyl)-1,3,4-oxadiazol-2-yl]-6-(trifluoromethyl)pyridine | 
| 2-Methyl-3-[5-(methylthio)-1,3,4-oxadiazol-2-yl]-6-(trifluoromethyl)pyridine |